Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Gonadorelin (GnRH) vs Human Chorionic Gonadotropin (HCG) — Peptide Comparison

Gonadorelin (GnRH) vs Human Chorionic Gonadotropin (HCG) — Peptide Comparison Gonadorelin (GnRH) vs Human Chorionic Gonadotropin (HCG) — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is… At a Glance Dose Range G

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

Gonadorelin (GnRH) vs Human Chorionic Gonadotropin (HCG) — Peptide Comparison Gonadorelin (GnRH) vs Human Chorionic Gonadotropin (HCG) — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is… At a Glance Dose Range Gonadorelin (GnRH) 0.1-1.5–3-10 mg Human Chorionic Gonadotropin (HCG) 250–2000 IU Frequency Once daily Twice weekly Administration Subcutaneous injection Cycle Length Ongoing/indefinite Onset Speed Moderate (1-2 weeks) Evidence Level Moderate human trials (Phase 1-2) Strong human trials (Phase 3 or FDA approved) Efficacy Reproductive Health Hormone Balance Ovulation Support Fertility Preservation Testicular Health Technical Data Molecular Formula C55H75N17O13 Molecular Weight 1182.3 Half-Life 2-4 minutes Bioavailability Varies by route: ~5-20% (intranasal), 100% (IV/IM injections) CAS Number 34973-08-5 C1105H1770N318O336S26 (approximate) 36,700 g/mol (approximately) 24-36 hours High when injected subcutaneously or intramuscularly 9002-61-3 Protocols standard 100 mcg Single dose One-time diagnostic test FDA-labeled gonadotropin (LH/FSH) stimulation test for pituitary reserve; 100 mcg given once subcutaneously (or IV), with LH measured at 0, 15, 30, 45, 60 and 120 minutes (Factrel) [4]. 5 mcg per pulse (range 1-20 mcg) Every 90 minutes via pulsatile pump One or more ovulatory cycles; reassessed at 21-day intervals FDA-labeled pulsatile regimen for ovulation induction in hypothalamic amenorrhea (Lutrepulse); intravenous pulsatile delivery gave better results than subcutaneous [5]. The 2-4 minute half-life makes pulsatile delivery essential. 500-1,500 IU 2-3 times per week Ongoing with TRT Documented clinical practice for preserving testicular function/fertility in men on testosterone therapy; 1,500-2,000 IU 2-3x/week is used for hypogonadotropic hypogonadism [6]. The popular 500 IU 2-3x/week maintenance figure reflects real-world practice rather than the FDA label. starting 500-1,000 IU 3 times weekly for 3 weeks, then 2 times weekly for 3 weeks 6-week induction course FDA-labeled regimen for male hypogonadotropic hypogonadism (Pregnyl) [7]. Intramuscular is the only labeled route. advanced 4,000 IU then taper to 2,000 IU 3 times weekly 4,000 IU for 6-9 months, then 2,000 IU for 3 additional months Higher-dose FDA-labeled regimen for inducing spermatogenesis/testicular descent (Pregnyl) [7]. Applications Improving fertility and conception chances Gonadorelin (GnRH) is particularly well-suited for individuals focused on improving fertility and conception chances. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Regulating irregular menstrual cycles Gonadorelin (GnRH) is particularly well-suited for individuals focused on regulating irregular menstrual cycles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Enhancing reproductive hormone levels Gonadorelin (GnRH) is particularly well-suited for individuals focused on enhancing reproductive hormone levels. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Supporting natural pregnancy attempts Gonadorelin (GnRH) is particularly well-suited for individuals focused on supporting natural pregnancy attempts. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Fertility Preservation During TRT If you're on testosterone therapy but want to keep your swimmers swimming, HCG is your best friend. It keeps your testes active and producing sperm even when external testosterone would normally shut that down. Research shows it can maintain or restore spermatogenesis in about 80% of men. Preventing Testicular Atrophy Nobody wants their boys to shrink. When you take external testosterone, your brain stops signaling your testes to work—and they get smaller from disuse. HCG mimics the signal (LH) that keeps them active, maintaining their size and function. Hypogonadotropic Hypogonadism If your pituitary gland isn't sending the right signals to your testes (low LH), HCG can step in and do the job. It's been used for decades to treat this condition, helping men achieve normal testosterone levels and fertility. Post-Cycle Therapy (PCT) After using anabolic steroids, your natural hormone production is suppressed. HCG can help jumpstart your testes back into action, speeding up the recovery of your natural testosterone production. It's often used as part of a comprehensive PCT protocol. Safety Profile Common Mild headache Local injection site reactions (redness, swelling) Temporary hot flashes Mood changes or emotional sensitivity Nausea or mild stomach upset Allergic skin reactions Dizziness or lightheadedness Temporary changes in vision Joint or muscle aches Insomnia or sleep disturbances Severe allergic reactions (difficulty breathing, swelling) Severe hormonal imbalance symptoms Ovarian hyperstimulation syndrome (OHSS) Signs of blood clots (chest pain, leg swelling) Severe mood changes or depression Serious Severe allergic reaction Injection site reactions Headache Water retention Uncommon Gynecomastia Mood changes Acne Blood clots Research Status FDA Status FDA approved for this use Safety Overview Gonadorelin is native GnRH and carries the safety profile established over 40+ years of clinical use in reproductive endocrinology. As the body's natural hormone, it produces minimal local side effects when dosed appropriately. The critical safety concern with gonadorelin is the initial flare effect within 24-48 hours of first dose—temporary elevation in FSH and LH—which can paradoxically suppress sex hormones before the desired stimulation occurs. This flare makes gonadorelin unsuitable for some conditions and explains why synthetic analogs (agonists, antagonists) are preferred in many modern fertility protocols. Contraindications xPregnancy or breastfeeding xHormone-sensitive cancers (breast, prostate, ovarian) xSevere pituitary or hypothalamic disease xUndiagnosed abnormal vaginal bleeding xKnown hypersensitivity to GnRH FDA approved for other use HCG has been used medically for over 80 years with a well-established safety profile. When used appropriately for male hypogonadism or fertility preservation, side effects are generally mild and manageable. The most common issues relate to elevated estrogen from increased testosterone aromatization, which can be managed with aromatase inhibitors if needed. Serious side effects are rare when HCG is used under medical supervision. xHormone-sensitive cancers (prostate, breast) xPrecocious puberty in children xKnown allergy to HCG or any component xPregnancy (in therapeutic male contexts) xUntreated thyroid or adrenal disorders Decision Guide Choose Gonadorelin (GnRH) if... Improving fertility and conception chances Regulating irregular menstrual cycles Enhancing reproductive hormone levels Supporting natural pregnancy attempts Choose Human Chorionic Gonadotropin (HCG) if... Fertility preservation during TRT Maintaining testicular size and function Natural testosterone stimulation Post-cycle therapy recovery